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Reciprocal regulation of lymphoid tissue
development in the large intestine by IL-25 and
IL-23
DS Donaldson1, BM Bradford1, D Artis2 and NA Mabbott1
Isolated lymphoid follicles (ILFs) develop after birth in the small and large intestines (SI and LI) and represent a dynamic
response of the gut immune system to themicrobiota. Despite their similarities, ILF development in the SI and LI differs
on a number of levels. We show that unlike ILF in the SI, the microbiota inhibits ILF development in the colon as
conventionalization of germ-free mice reduced colonic ILFs. From this, we identified a novel mechanism regulating
colonic ILF development through the action of interleukin (IL)-25 on IL-23 and its ability to modulate T regulatory cell
(Treg) differentiation. Colonic ILF develop in the absence of a number of factors required for the development of their SI
counterparts and can be specifically suppressed by factors other than IL-25. However, IL-23 is the only factor identified
that specifically promotes colonic ILFs without affecting SI-ILF development. Both IL-23 and ILFs are associated with
inflammatory bowel disease, suggesting that disruption to this pathwaymay have an important role in the breakdownof
microbiota-immune homeostasis.
INTRODUCTION
The intestinal microbiota has a profound effect on the host,
highlighted by the fact that alterations have been associated
with a number of pathologies and less favorable outcomes in
disease models.1 Central to this effect is the homeostasis that is
reached between the intestinalmicrobiota and the host immune
system. Cross-talk between the host immune system and the
microbiota is critical for the development of the gut immune
system and the gut-associated lymphoid tissue that in turn
regulates the microbiota.2 Disturbance of this balance has been
implicated in the development of intestinal pathology and
intestinal lymphoid tissues have been associated with human
inflammatory bowel disease and increased pathology in mouse
models.3–6One pronounced effect of themicrobiota on the host
is the dynamic regulation of isolated lymphoid follicle (ILF)
development,7,8 single B-cell follicles that act as inductive sites
for immunoglobulin A (IgA) production.9
The gut-associated lymphoid tissue consists of multifolli-
cular Peyer’s patches and similar structures within the large
intestine (LI) that develop in utero,10 in addition to a conti-
nuum of smaller structures, referred to as solitary isolated
lymphoid tissue that develops after birth.7,8 The smallest of
these, termed cryptopatches (CPs), consist primarily of retinoic
acid-related orphan receptor (ROR)-gtþ innate lymphoid cells
(ILCs).11,12 CPs are considered to develop into single B-cell
follicle-containing ILFs. ILFs exist in a range of sizes, with the
larger displaying germinal center characteristics (e.g., follicular
dendritic cell networks) and referred to as mature ILFs
(mILFs).8,13,14 Although lymphotoxin-a/b (LTa1/b2) is
required for Peyer’s patches and ILF development, the postnatal
development of CPs and ILFs requires additional environ-
mental signals. CPs are reduced in mice lacking the aryl
hydrocarbon receptor or fed a diet lacking the natural ligands
for this receptor,15 but are present in germ-free mice. ILFs are
reduced in the small intestines (SI) of germ-free mice and
microbial colonization induces their development.8 Antibiotic
treatment also reduces ILFs in the SI, supporting a central role
for themicrobiota in both the induction andmaintenance of SI-
ILFs.16,17 An additional microbiota-dependent, but CP-inde-
pendent, B-cell aggregate has been described in the colon of
LTa / and RORgt / mice, referred to as tertiary lymphoid
tissues (tLTs).6,18
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ILF development in the SI is dependent on a number of
factors involved in lympho-organogenesis.7,14,19,20 ILFs are also
reduced or absent in mice lacking microbial recognition
molecules, such as myeloid differentiation primary response
gene 88, nucleotide-binding oligomerization domain-contain-
ing protein-2 (NOD2) and NOD1.16 Interestingly, although
some of these factors also block ILF development in the LI, mice
that lack RANKL (receptor activator of NF-kB ligand),19 or
CXCL13,21 still develop ILF-like structures in the colon.
Colonic ILFs also develop earlier than their SI counterparts
and have been observed in germ-free and antibiotic-treated
mice, suggesting that the regulation of LI-ILF development
differs significantly from SI-ILFs.16,17,21 The basis for this
differential regulation is undetermined.
Here, we have identified a novel colon-specific regulatory
loop of ILF development in the steady state mediated by
interleukin (IL)-25 and IL-23. Our observation that conven-
tionalization of germ-free mice specifically reduced LI-ILFs,
and that IL-25 / and IL-23p19 / mice have alterations in
colonic ILFs, suggest that themicrobiota regulates ILFs in the LI
by modulating expression of these cytokines. Thus, our data
suggest that the reciprocal regulation of colonic ILF develop-
ment by IL-25 and IL-23 has important implications for the
understanding of immune-microbiota homeostasis and the
development of intestinal pathology.
RESULTS
LI-ILF development and maturation is inhibited by the
microbiota
Murine intestines contain a number of organized lymphoid
tissues with differential developmental origins. Multifollicular
Peyer’s patches and their equivalents in the LI develop in utero,
whereas solitary B-cell aggregates, referred to as ILFs, develop
after birth from CPs. Colonic tLTs may also develop after birth,
but these currently cannot be differentiated from ILFs in mice
with CPs by immunohistochemistry alone.18 LI-ILFs can be
easily differentiated from patches in tissue sections. For
example, colonic patches are multifollicular, extend into the
submucosa, and contain defined T-cell areas, whereas LI-ILFs
are solitary, are located only in the lamina propria (LP), and lack
defined T-cell areas21 (Figure 1a). Although these same criteria
cannot be applied after whole-mount immunostaining of B
cells, patches can be readily differentiated by whole-mount
immunostaining (Figure 1b) by their multifollicular nature
that may not always be apparent in tissue sections. Despite this,
some colonic patches may be single domed and thus difficult to
differentiate from large ILFs. However, these are few in
number21 and vastly outweighed by the larger numbers of ILFs.
Analysis by whole-mount immunostaining remains a superior
method to analyze total ILF numbers by reducing sample bias
and the effects of ILF enlargement. A small number of ILFs
contain follicular dendritic cell networks, visualized by staining
with anti-CD35 monoclonal antibody (mAb), and are con-
sidered to bemILFs (Figure 1c). CPs consist of ILCs and can be
visualized by immunostaining for Thy1 (Figure 1a). The
development of CPs is independent of the microbiota, whereas
SI-ILF development is predominantly microbiota depen-
dent.8,14,16,17 The effect of the microbiota on LI-ILFs is more
variable, as unlike the reduced ILFs observed in the SI of
germ-free and antibiotic-treated mice, colonic ILFs have been
reported to develop similarly in specific pathogen-free (SPF)
and germ-free mice and to be less affected by antibiotic
treatment.17,21
Using whole-mount immunostaining with anti-B220 mAb
to detect B-cell aggregates (ILFs) and anti-CD35mAb to detect
follicular dendritic cell networks (mILFs), our own analysis of
total ILF and mILF numbers in germ-free mice supported the
microbial independence of ILF development andmaturation in
the LI. In germ-free mice, ILFs were rarely detected in the SI,
whereas the LI contained numerous ILFs and mILFs
(Figure 2a,b). To show that no further ILF development
occurred in the presence of themicrobiota, germ-freemicewere
transferred to conventional housing and their intestines whole-
mount immunostained as above. As expected, conven-
tionalization induced a significant increase in ileal ILFs and
mILFs (Figure 2c). Interestingly, not only did no further ILF
development occur in the cecum and colon of conventionalized
mice, a significant reduction in both colonic ILFs and mILFs
was observed, associated with a significantly decreased ILF
size in the distal colon. IL-25 is produced by the intestinal
epithelium in response to the microbiota resulting in reduced
ILC responses and IL-23 expression22,23 and thus may be
involved in ILF regulation. Our analysis confirmed that
Il25 mRNA was significantly upregulated in the colon of
conventionalized mice, correlating with the reduction in ILFs
(Figure 2d). These data demonstrate that colonic ILFs, in
contrast to their SI counterparts, can be negatively regulated by
the microbiota.
IL-25 / mice have increased LI-ILFs
To test whether IL-25 had a role in colonic ILF development,
ILFs and mILFs were enumerated in the intestines of wild-type
(WT) mice and IL-25 / mice (Figure 3a). IL-25 / mice
had decreased SI-ILFs, particularly in the ileum (Figure 3b). In
contrast, the LI contained significantly higher ILFs. SI-mILF
numbers were unaltered, whereas the LI had significantly
higher mILFs. There was no significant difference in CP
numbers in the ileum or colon of WT and IL-25 / mice
(Figure 3c,d), suggesting IL-25 acts duringCP to ILF transition.
IL-23 is composed of the IL-23p19 and IL-12p40 subunits
and, in accordance with previous studies, expression of Il23a
and Il12b mRNAs were significantly increased in the colon of
IL-25 / mice23 (Figure 4a). Although IL-25 / mice have
been shown toharbor an increased population of RORgtþ ILCs
in the SI,22 no difference in Rorc mRNA expression was
observed in the colon. Consistent with the increased numbers
of ILFs, significant increases in the expression of chemokines
important for lympho-organogenesis and lymphocyte recruit-
ment (Ccl20, Cxcl13, and Ccl19) were observed in the colon of
IL-25 / mice (Figure 4b). These data suggest that the
inhibitory effect of the microbiota on ILF development in the
colon was because of increased IL-25 production.
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IL-25 / mice have increased colonic B cells, IgA
production, and Th1 cells
Increased colonic ILFs would likely alter lymphocyte retention
and differentiation in the colon. To determine the effect of
increased colonic ILFs in IL-25 / mice on lymphocytes,
colonic LP, mesenteric lymph node (MLN), and spleen cells
were isolated from WT and IL-25 / mice and analyzed
by flow cytometry. Although splenic cellularity was similar
in WT and IL-25 / mice, a significant reduction in
MLN cellularity was observed (Figure 5a). No difference in
the total colonic LP cells was observed (data not shown). IL-
25 / mice had a significant increase in the proportion and
absolute number of B220þ B cells in the colonic LP
(Figure 5b). ILFs are sites of IgA induction9 and, accordingly,
IL-25 / mice also had a significant increase in the proportion
of B220þ cells that were IgAþ in the colonic LP (Figure 5c)
and a significant increase in fecal IgA (Figure 5d). These data
suggest that as a consequence of increased ILFs in IL-25 /
mice, B cells were being retained within the colon, driving
higher levels of IgA production.
The proportion of CD3þCD4þ T cells within the colonic
LP, MLN, and spleen was also significantly increased in
IL-25 / mice (Figure 5e). The absolute CD3þCD4þ T-cell
number was significantly increased in the colonic LP and
spleen, but not the MLN. Within this population, a significant
increase in T-betþ T helper type 1 (Th1) cells and a significant
decrease in RORgtþ Th17 cells was observed in the colonic LP
(Figure 5f). T-betþ Th1 cells were unchanged in theMLN, but
a significant increase was observed in the spleen. RORgtþ Th17
cells were not readily detectable in the MLN and spleen.
Therefore, increased ILFs in IL-25 / mice are associatedwith
an expansion of Th1 cells in the colonic LP.
IL-23p19 / mice have a colon-specific reduction in ILFs
IL-23 is implicated in the pathogenesis of a number of
inflammatory diseases, particularly colitis,24 and is increased in
Figure 1 Gastrointestinal lymphoid tissue of the small and large intestines. (a) Sections of small and large intestine were stained for Thy1 (red), B220
(green), and nuclei (blue) to detect cryptopatches, isolated lymphoid follicles, and multifollicular patches (Peyer’s patches in the small intestine and
colonic patches in the large intestine). Bar¼500 mm in low power panels and 200 mm in higher power panels. (b) Intestinal segments were whole-mount
stained for B220 (green) and CD35 (red) to detect multifollicular patches and isolated lymphoid follicles. Bar¼200 mm. (c) Mature isolated lymphoid
follicles can be differentiated by CD35 staining (red), visualizing follicular dendritic cell networks. Bar¼ 50mm.
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the colon of germ-free and IL-25 / mice.23 Microbiota-
induced IL-25 reduces colonic IL-23 expression in germ-free
mice following colonization.23 IL-23 induces IL-17 and IL-22
from ILCs,25 both of which may have roles in lympho-
organogenesis,26,27 suggesting the effect of IL-25 on ILFs may
be its ability to reduce IL-23 production. To test this, the
intestines of IL-23p19 / and WT mice were whole-mount
immunostained and ILF counted (Figure 6a). The SI, cecum,
and proximal colon contained equivalent numbers of ILFs
(Figure 6b). However, a significant reduction in distal colonic
ILFs was observed in IL-23p19 / mice. ILF size was also
reduced throughout the intestines, particularly in the distal
colon. Equivalent numbers of CPs were observed in the ileum
and colon of WT and IL-23p19 / mice (Figure 6c,d),
suggesting the effect of IL-23 was occurring during CP to ILF
transition, correlating with the effect of IL-25. Colonic Il25
mRNA expression was also equivalent (Figure 6e), suggesting
the effect on ILFs was not because of increased IL-25 and that
the effect of IL-23 on ILF development was downstream of the
effect of IL-25.
The changes in colonic ILFs in both IL-25 / and IL-
23p19 / mice may have been the result of altered microbial
burdens and/or altered microbiota composition. Total bacteria
and the relative proportions of major phyla were analyzed in
fecal samples by quantitative real-time reverse-transcriptase–
PCR using primers specific for bacterial 16S rRNA. No
difference in the total fecal microbial burden was observed
between IL-25 / or IL-23p19 / mice and respective WT
mice (Supplementary Figure S1 online). Furthermore, no
significant changes were observed in the composition of the
microbiota, with the exception of segmented filamentous
bacteria (SFB), that was significantly increased in IL-25 /
mice. This suggests that the differential numbers of ILFs
observed in these models was not because of major alterations
in the size or composition of the microbiota.
To determine whether the effect of IL-23 was dependent on
IL-17 or IL-22, mice treated with LTbR-Ig in utero, which
blocks Peyer’s patch development, but not CP and ILFs,16 were
given neutralizing anti-IL-17 or anti-IL-22 (or isotype-matched
controls) between days 14 and 28 after birth. Higher ILF
Figure 2 Isolated lymphoid follicle (ILF) development and maturation in the large intestine (LI) of germ-free mice is suppressed by the microbiota.
(a) Alternate 3 cm sections of small intestine (SI) and the whole LI were whole-mount immunostained for B220 (green) to detect ILFs and CD35 (red) to
detect mature ILFs (mILFs). Representative images of SI and LI are shown. White arrowheads highlight immature ILFs and red arrowheads highlight
mILFs. Bar¼500mm. (b) The total number of ILFs andmILFs in the SI and LI of germ-free mice was determined bymicroscopy (n¼ 3). SI numbers were
estimated from representative sections. (c) The number of ILFs and mILFs and the mean ILF size were determined in the intestines of germ-free and
conventionalizedgerm-freemicebymicroscopy (n¼ 3). (d) The relative level of Il25mRNAexpression in thecolonof germ-freeandconventionalizedmice
was determined by quantitative real-time reverse-transcriptase–PCR (qRT–PCR; n¼3). Statistical differences were determined by Student’s t-test
(*Po0.05).
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Figure 3 Interleukin (IL)-25 / mice have increased large intestinal (LI) isolated lymphoid follicles (ILFs). (a) Alternate 4 cm sections of small intestine
(SI) and the whole LI of wild-type (WT) and IL-25 / mice were whole-mount immunostained for B220 (green) to detect ILFs and CD35 (red) to detect
mature ILFs (mILFs). Representative images of ileumand distal colon are shown. Bar¼ 500 mm. (b) Total ILF andmILF numbers andmean ILF sizewere
determined by microscopy (n¼8). Results are representative of two independent experiments. (c) Sections of ileum and colon were stained for Thy1
(red), B220 (green), andnuclei (blue) to detect cryptopatches (CPs). Bar¼50 mm. (d)CPnumbers in 20 sections (100mmapart) of 10 cmof terminal ileum
or the whole colon were determined by microscopy and converted to CP/section (n¼ 4). Statistical differences were determined by Student’s t-test
(*Po0.05).
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numbers develop in LTbR-Ig-treated mice allowing a greater
range for the effect of cytokine neutralization in youngmice and
excluding confusion with underdeveloped patches. The intes-
tines were whole-mount immunostained and ILFs and mILFs
enumerated as before. Blocking IL-17 or IL-22 did not
significantly alter the total ILF or mILF number or size in
the SI or LI (Supplementary Figure 2a and b). This suggests
that IL-17 and IL-22 were not the primary downstream factors
of IL-23-mediated regulation of ILFs, implying that IL-23 has
additional roles.
Depletion of CD25þ T regulatory cells (Tregs) increases ILF
density
Germ-free mice have reduced colonic Tregs that is reversed by
colonization, whereas SI Tregs are unaffected.28 IL-23 may a
play a role in this as T cells transferred into RAG1 / IL-
23p19 / mice develop higher numbers of Tregs, suggesting
that IL-23 restrains Treg development.29 Following transfer, T
cells migrate to colonic CPs before the development of colitis5
and colonic ILFs contain higher Foxp3 mRNA than the LP.4
Our immunohistochemical analysis showed that CD3þ
Foxp3þ cells were detectable within ileal and colonic ILFs
(Figure 7a) and quantification revealed a significant
enrichment in ILFs (Figure 7b). The percentage of Foxp3þ
cells was significantly higher in ILFs compared with LP,
suggesting enrichment was not because of higher T-cell den-
sities. Analysis of ILFs from germ-free and conventionalized
mice showed that the density of CD3þFoxp3þ cells within
ILFs significantly increased following colonization (Figure 7c).
Furthermore, the proportion ofCD3þCD4þ Tcells expressing
Foxp3 was significantly reduced in the colonic LP of IL-25 /
mice (Figure 7d,e) similar to germ-free mice. These data
suggest that although Tregs are enriched in colonic ILFs, the
proportion of Tregs negatively correlates with the number of
colonic ILFs, implying a role for Tregs in ILF development.
Some Tregs have been reported to express IL-23 receptor (IL-
23R).30 Analysis of CD3þCD4þFoxp3þ cells from the MLN,
SI-LP, and colonic LP showed that a subpopulation of intestinal
Tregs express IL-23R that was virtually absent in the MLN
(Figure 7f), suggesting that IL-23 could directly modulate Treg
differentiation in the intestines.
To determine the role of Tregs in ILF development, CD25þ
Tregs were depleted with anti-CD25 mAb. After 14 days, the
proportion of CD4þCD25þFoxp3þ cells in the LP were
determined by flow cytometry. Anti-CD25 mAb treatment
effectively depletedCD4þCD25þFoxp3þ cells in the LP of the
SI and colon (Figure 7g). ILFs were determined by whole-
mount immunostaining as before in 8 cm sections of terminal
ileum and the colon. Anti-CD25 mAb depletion induced a
significant increase in ileal and colonic ILFs (Figure 7h).
Increased mILFs were also observed, but this was not
significant. Anti-CD25 mAb treatment did not significantly
alter CP numbers in the SI or colon (Figure 7i). Therefore,
depletion of CD25þ Tregs increased numbers of ILFs,
suggesting that Tregs regulate CP to ILF transition.
IL-23p19þ cells are enriched in colonic ILFs
Treg depletion affected both SI- and LI-ILF development
(Figure 7h). However, colonization of germ-free mice only
inhibited colon ILF (Figure 2c). Colonic, but not SI, Tregs have
been shown to increase following colonization,28 suggesting
that a colon-specific factor may underlie both of these effects.
Microbiota-induced IL-25 is expressed throughout the intes-
tines, whereas IL-23 expression in the colon mirrors the effect
Figure 4 The expression of Il23a, Il12b,Ccl20,Cxcl13, andCcl19mRNA is increased in the colon of interleukin (IL)-25 / mice. (a) The relative levels
of Il23a, Il12b, andRorcmRNA expression in the colon of wild-type and IL-25 / mice were determined by quantitative real-time reverse-transcriptase–
PCR (qRT–PCR; n¼ 3). (b) The relative levels of Ccl20, Cxcl13, and Ccl19 mRNA expression in the colon of wild-type and IL-25 / mice were
determined by qRT–PCR (n¼ 3). Results are representative of two independent experiments. Statistical differences were determined by Student’s t-test
(*Po0.05).
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on ILFs, in that it is specifically higher in the colon of germ-free
mice and reduced upon colonization.23 To determine the
cellular source of IL-23 that affects ILF development, irradiated
LTb / mice were reconstituted with bone marrow (BM)
from either WT or IL-23p19 / mice (WT-LTb / and
IL-23p19 /-LTb / mice) and ILFs and mILFs were
enumerated in the intestines as above. LTb / mice lack gut-
associated lymphoid tissues; however, reconstitution with
LTb-sufficient BM induces CP and ILF development.31 No
difference in ILF numbers was observed in the SI or the
proximal colon ofWT-LTb / or IL-23p19 /-LTb /
mice, whereas a significant reduction was observed in the
distal colon of IL-23p19 /-LTb / mice (Figure 8a).
This was associated with a significant reduction in colonic
Figure 5 Interleukin (IL)-25 / mice have increased colonic B cells, immunoglobulin A (IgA) responses, and T helper type 1 (Th1) cells. (a) Mesenteric
lymphnode (MLN)and spleen cells fromwild-type (WT) and IL-25 / micewere isolated and counted (n¼4). (b) The relative frequencyofB220þ Bcells
in the colonic lamina propria (LP), MLN, and spleen ofWT and IL-25 / mice was determined by flow cytometry and the absolute cell number calculated
(n¼ 4). Representative histograms are shown. (c) The proportion of B220þ cells that express IgA in the colonic LP was determined by flow cytometry
(n¼ 3). (d) Homogenates of fecal pellets (10%) from wild-type and IL-25 / mice were prepared in phosphate-buffered saline (PBS) and IgA levels
determinedby enzyme-linked immunosorbent assay (ELISA; n¼ 4). Absolute valueswere calculated fromastandard curve of controlmouse IgA. (e) The
relative frequencyofCD3þCD4þ Tcells in the colonic LP,MLN, andspleenofWTand IL-25 / micewasdeterminedby flowcytometry and theabsolute
cell number calculated (n¼ 4). (f) The relative frequency of T-betþ and RORgtþ cells in CD3þCD4þ T-cell population from the colonic LP, MLN, and
spleen of WT and IL-25 / mice. Representative histograms are shown. Results are representative of three independent experiments. Statistical
differences were determined by Student’s t-test (*Po0.05, **Po0.01).
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mILFs (Figure 8b) and a reduction in distal colonic ILF size
(Figure 8c), paralleling the phenotype of IL-23p19 / mice
(Figure 6b). This showed that the effect of IL-23 deficiency was
because of production by a cell of hematopoietic origin in the
colon.
IL-23p19 is thought to be expressed by mononuclear
phagocytes in the colon.32,33 Immunohistochemical analysis
showed that IL-23p19þ cells in colonic ILFs coexpressed
CD11c, suggesting a mononuclear phagocyte origin for
colonic IL-23 (Figure 9a). This was supported by analysis
of a large range of microarray data sets (4200) representing 95
distinct murine tissues or cell lineages that confirmed
that expression of Il23a, encoding IL-23p19, was restricted
to CD11c-epxressing cells (Supplementary Figure S3).
CD11cþ cells are critical for SI-ILF development.34
To determine their role in LI-ILF development, irradiated
LTb / mice were reconstituted with BM from CD11c-DTR
mice. Mice were treated with diphtheria toxin to deplete
CD11c-expressing cells and 2 or 7 days later the colons were
whole-mount immunostained to detect ILFs and mILFs as
before. CD11cþ cell depletion induced a significant reduction
in total ILFs and mILFs in the colon (Figure 9b), affirming the
critical role for this population in LI-ILF development.
Interestingly, although IL-23p19þ cells were detectable in
the LP of the SI, they were rarely within ILFs (Figure 9c). In
contrast, IL-23p19þ cells were readily detected in colonic ILFs.
Quantification revealed that colonic ILFs contained
significantly higher densities of IL-23p19þ cells than
Figure 6 Interleukin (IL)-23p19 / mice have a colon-specific reduction in isolated lymphoid follicles (ILFs). (a) Alternate 4 cm sections of small
intestine (SI) and the whole large intestine from wild-type (WT) or IL-23p19 / mice were whole-mount immunostained for B220 (red) to detect ILFs.
Bar¼ 500 mm. (b) ILF numbers and mean ILF size in WT or IL-23p19 / mice was determined by microscopy (n¼4). (c) Sections of ileum and colon
were stained for Thy1 (red), B220 (green), and nuclei (blue) to detect cryptopatches (CPs). Bar¼ 50mm. (d) CP numbers in 20 sections (100 mmapart) of
10 cm of terminal ileum or the whole colon were determined by microscopy and converted to CP/section (n¼4). (e) The relative level of Il25 mRNA
expression in the colon ofWTand IL-23p19 / micewas determined by quantitative real-time reverse-transcriptase–PCR (qRT–PCR; n¼4). Statistical
differences were determined by Student’s t-test (*Po0.05).
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SI-ILFs (Figure 9d). Furthermore, enumeration of IL-23p19þ
cells within colonic ILFs of germ-free and conventionalized
mice revealed a significant decrease in this population upon
microbial colonization (Figure 9e), consistent with previous
observations23 and supporting a role for modulation of this
population in the regulation of colonic ILFs. Therefore,
CD11cþ IL-23p19þ cells are specifically enriched in colonic
ILFs and may underlie the colon-specific regulation of ILF
development by IL-25, IL-23, and Tregs.
DISCUSSION
In this study, a novel system regulating ILF development in the
colon has been identified. Unlike the SI, where the microbiota
promotes ILF development, our studies show that conversely,
the microbiota can inhibit colonic ILF development. These
contrasting microbiota-driven changes led us to consider the
roles of IL-25 and IL-23, both regulated by the microbiota, in
colonic ILF development. We found that in the absence of IL-
25, colonic ILF development was enhanced. This was associated
Figure 7 Anti-CD25 treatment enhances isolated lymphoid follicle (ILF) numbers in the ileum and colon. (a) Sections of small intestine (SI) and large
intestine (LI) were immunostained for B220 (blue), CD3 (green), and Foxp3 (red). Representative images of ILFs from the ileum and colon are shown.
Bar¼ 20mm. (b) The number of CD3þFoxp3þ cells and the proportion of CD3þ cells expressing Foxp3within ILFs and adjacent areas of lamina propria
(LP) were determined by microscopy (n¼ 3). (c) The number of CD3þFoxp3þ within ILFs of germ-free and conventionalized mice (n¼ 3) (d, e) The
relative frequencyofFoxp3þ cells in theCD3þCD4þ T-cell population of the colonic LP,mesenteric lymphnode (MLN), andspleenofwild-type (WT)and
interleukin (IL)-25 / mice was determined by flow cytometry. Representative histograms are shown (n¼4). (f) The relative frequency of IL-23Rþ cells
within theCD4þFoxp3þ Tcell population of theMLN, ileum, and colonwas determinedby flow cytometry (n¼3). (g)Micewere treatedwith anti-CD25 or
control Ig. At 7 daysafter final treatment,micewere killed and theproportion ofCD25þFoxp3þ cellswithin theCD4þ population of the ileal andcolonic LP
were determined by flow cytometry (n¼ 4). (h) Portions of terminal ileum (8 cm) and the whole colon of anti-CD25 or control Ig-treatedmice were whole-
mount immunostained for B220 andCD35 to detect ILFs andmature ILFs (mILFs), respectively. ILF andmILF numbers were determined bymicroscopy
(n¼ 4). (i) Sections of ileum and colon were stained for Thy1 (red) and B220 (green) to detect cryptopatches (CPs). CP numbers in 12 sections (100 mm
apart) of 10 cm of terminal ileum or the whole colon were determined by microscopy and converted to CP/section (n¼4). Statistical differences were
determined by Student’s t-test (*Po0.05, **Po0.01, NS, not significant).
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with increased colonic IL-23 expression23 and, accordingly, IL-
23p19 / mice had a colon-specific decrease in ILFs. The
specificity is likely because of the enrichment of IL-23p19þ
CD11cþ cells within colonic ILFs and their ability to modulate
Treg differentiation. Colonic ILFs develop in the absence of a
number of factors required for the development of their SI
counterparts.18,19,21 In addition, colonic ILFs, but not SI-ILFs, can
also be suppressed by thymic stromal lymphopoietin (TSLP)35 in
addition to IL-25. However, IL-23 is the only factor identified to
date that specifically promotes colonic ILFswithout affecting ILFs
in the SI. Given the important role of IL-23 in inflammatory
bowel disease,24 we believe that this may represent a novel
function for IL-23 in the pathogenesis of colitis.
Themodel these data suggest is that in absence ofmicrobiota,
IL-25 production is diminished,22,23 leading to increased
IL-23 secretion by CD11cþ cells (Supplementary
Figure S4a). Increased IL-23 may suppress colonic Treg
development,29 leading to reduced Treg suppression of ILF
development and increased ILF numbers. Following coloniza-
tion, both microbial16 and endogenous stimulation drive
ILF development (Supplementary Figure S4b); however,
this is now associated with increased microbiota-induced
IL-25.23 The increased IL-25 leads to reduced IL-23 secretion by
CD11cþ cells, permitting the expansion of colonic Tregs and
suppressed colonic ILF development. SI-ILFs are not regulated
by IL-25, likely because of the rarity of CD11cþ cells expressing
IL-23 within SI-ILFs.
In addition to ILFs, the colonmay contain tLTs that develop in
response to inflammation independent ofCPs.24 It is conceivable
that some of the increased ILFs in germ-free and IL-25 / mice
were tLTs.These are indistinguishable from ILFshistologically in
that they are single B-cell follicles without defined T-cell zones
and can only be defined in mice that lack CPs. To determine the
contribution of tLTs, RORgt / mice,18 which lack CPs, or
mice treated with LTbR-Ig during early life,16 which blocks CP
development, could be used. However, the extent to which tLT
development in thesemodels is a consequence ofCP/ILFabsence
and/or the loss of other cell populations (e.g., Th17 cells in
RORgt / mice) is unclear. These complicationsmean that it is
unknown how many tLTs contribute to total colonic B-cell
aggregates in CP-containing mice. The pathways controlling
inducible bronchus-associated lymphoid tissue development,
which can also form independent of RORgtþ cells,26 show some
similarities to colonic B-cell aggregates in that they both require
LT and CD11cþ cells,26,36 can be inhibited by Tregs,37 and show
some dependence on IL-23.26 This suggests similarities exist in
the pathways that regulate RORgt-dependent and -independent
structures, confounding the difficulties in delineating the roles of
each structure.
Consistent with previous studies, we observed minimal ileal
ILFs in germ-free mice.8,16 Despite this, duodenal and jejunal
ILFs were present, although in low numbers, and were
unaltered by conventionalization. Our own study of the timing
of ILF development after birth showed a similar pattern, with
higher duodenal and jejunal ILF development at early ages (up
to 4weeks) followed by ileal ILF development (4–6weeks) (data
not shown). This suggests that at least some SI-ILF develop-
ment is microbiota independent and that SI-ILF development
in germ-free mice broadly resembles that of SPF-housed mice.
Colonic ILFs develop earlier than ileal ILFs,17 and the number
of ILFs in the colon of germ-free mice has been reported to be
similar to that of SPF-housed mice,17,21,35 suggesting that
colonic ILF development also proceeds normally in germ-free
mice. It has been reported that the colonic epithelium
undergoes irreversible epigenetic changes in the absence of
themicrobiota,38 and to what extent such changes contribute to
ILF development is undetermined.
The role of the microbiota in the regulation of colonic ILF
remains controversial. Colonization with restricted flora has
been shown to promote colonic ILF development,16 and a
number of studies have shown that colonic B-cell aggregates
develop in the absence of factors (e.g., RANK,19 CXCL13,21
RORgt,18 and LTa6) necessary for SI-ILF development,
suggesting that some form of colonic B-cell aggregate is
Figure 8 LTb / mice reconstituted with interleukin (IL)-23p19 /
bone marrow have a specific reduction in colonic isolated lymphoid
follicles (ILFs). LTb / were lethally irradiatedand reconstitutedwithwild-
type (wt) or IL-23p19 / bone marrow. After 10 weeks, alternate 4 cm
sections of small intestine (SI) and colon were whole-mount
immunostained for B220 and CD35 to detect ILFs and mature ILFs
(mILFs), respectively. (a) Total ILF and (b) mILF numbers were
determined by microscopy (n¼4). SI values are the mean ILF or mILF
numbers present in a 4-cm section of SI (5 sections/mouse). (c) Mean ILF
size was also determined. Statistical differences were determined by
Student’s t-test (*Po0.05).
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critically required for microbiota homeostasis. However, the
finding in the current and other studies17,21 that germ-free and
antibiotic-treated mice have equivalent or higher numbers of
ILFs compared with SPFmice is difficult to reconcile with these
data. ILFs are dynamically regulated and show both temporal
and spatial variation throughout the colon, meaning that
interpretation of these studies is confounded by the differential
mouse strains, sampling of the colon, and methodologies used
to identify ILFs, as well as extrinsic factors such as the
composition of the microbiota. Our study reconciles some of
the discrepancies by showing that dramatic changes in colonic
ILFs occur following colonization. Colonization diminished
but did not ablate colonic ILFs, supporting the notion that
microbiota-independent ILF development is an inappropriate
and exaggerated response that is ill-equipped to mediate
homeostasis. Therefore, a combination of both pro- and anti-
ILF signals from the microbiota are likely required to develop
an appropriate ILF response and homeostasis with the
microbiota. Given the association between colonic lymphoid
aggregates and enhanced pathology,3,6,39 understanding how
this exaggerated response is regulated by nonmicrobial factors
(e.g., IL-23) may aid our understanding of susceptibility to
colonic inflammation.
No differences in the overall fecal microbial burden were
observed in IL-25 / or IL-23 / mice, suggesting that the
differences in ILF development were not because of alterations
in microbial burden. Altered microbiota composition could
drive differential responses (e.g., increased IL-25), but micro-
biota profiling revealed similar levels of all phyla measured,
with the exception of SFB that was significantly increased in IL-
25 / mice. Mono-colonization with SFB, but not Escherichia
coli, has recently been shown to drive the formation of tLTs in SI
in the absence of CPs; however, both were equally able to drive
ILF development in the presence of CPs.40 However, in this
study, ileal ILFs were significantly reduced in IL-25 / mice,
suggesting that changes in ILF development in the absence of
IL-25 were not because of SFB. Interestingly, SFB specifically
colonizes the epithelium overlying lymphoid follicles,41 and the
relative proportion of SFB correlated with the number of
colonic ILFs, suggesting that changes in SFB abundance may
relate to the number of available follicles for colonization.
Microbial colonization also induces TSLP production by
colonic CD11cþ cells.35 TSLPR / and IL-25 / mice
sharemany similarities in that they have increased colonic ILFs,
Figure 9 Interleukin (IL)-23p19þ cells are enriched in colonic isolated
lymphoid follicles (ILFs). (a) Sections of colonic ILFs were also
immunostained for B220 (blue), IL-23p19 (red), and CD11c (green).
Bar¼ 20mm in the left panel and 5 mm in the right panel. (b) LTb / were
irradiated and reconstituted with bone marrow from CD11c-DTR mice.
Mice were treated with diphtheria toxin (DTX) and culled 2 or 7 days after
treatment. Phosphate-buffered saline (PBS)-treated mice culled 7 days
after treatment were included as controls. The colon of each mouse was
whole-mount immunostained for B220 to detect ILFs and CD35 to detect
mature ILFs (mILFs). ILF and mILF numbers were determined by
microscopy (n¼ 3–4). (c) Sections of small intestine (SI) and colon from
wild-type mice were immunostained for B220 (blue) and IL-23p19 (red).
Representative images of ILF are shown. Bar¼40 mm in the upper panel
and 20mm in the lower panel. (d) IL-23p19þ cells within ILFs or adjacent
areas of lamina propria (LP) were enumerated and the density of
IL-23p19þ cells determined (n¼3). (e) IL-23p19þ cells within ILFs of
germ-free and conventionalized mice were enumerated and the density
of IL-23p19þ cells determined (n¼ 3). Statistical differences were
determined by Student’s t-test (*Po0.05).
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altered Treg populations, and increased T cells secreting
interferon-g and IL-17.35 This phenotypic similarity suggests a
common mechanism underlying the effect of microbial-
induced IL-25 and TSLP. If so, this is unlikely to be because
of SFB, as TSLPR / mice show no difference in the relative
abundance of SFB. Thus, the effect of IL-25 or IL-23 deficiency
on ILF development is unlikely to be because of alterations in
the composition or the size of the microbiota.
Tregs are preferentially located in colonic ILFs of humans
and mice.4,42 Increased colonic ILFs and IL-23 in both germ-
free and IL-25 / mice was accompanied by reductions in
Tregs. IL-23 has been shown to limit Treg numbers in the
colon,29 but the mechanism remains unclear. A subpopulation
of intestinal Tregs expressed IL-23R, suggesting that IL-23 may
directly affect these cells. IL-23R expression is under the control
of RORgt,43 and intestinal Foxp3þRORgtþ T cells have been
described.44 Therefore, IL-23R expression by Foxp3þ cellsmay
be indicative of a differentiating cell rather than a differentiated
cell. In support of this, increasedTregs observed in IL-23p19 /
RAG-1 / mice were derived from naive CD4þ T cells rather
than CD4þFoxp3þ T cells.29 Absence of TSLPR also led to a
reduction in induced Tregs without affecting thymically
derived Tregs.35 These data imply that IL-23 acts during de
novo Treg differentiation, either by repressing Foxp3 or
promoting Th17 differentiation.
Our data suggest that Tregs play an important role in ILF
regulation. How Tregs influence ILF development is unclear.
Tregs are present in the follicles of secondary lymphoid organs
where they limit the germinal center response by suppressing
other follicular T-cell subsets and limiting nonantigen-specific
B-cell recruitment.45 In our study, Tregs were present within
immature ILFs and depletion of Tregs only had amarginal effect
on ILF maturation (data not shown), suggesting their action
might be before germinal center formation. Consistent with this
hypothesis, Treg depletiondid not affectCPnumbers, suggesting
they inhibit CP to ILF transition. This requiresCD11cþ cells and
the production ofCXCL13 by this population.34 Tregs are potent
inhibitors of CD11cþ cell function, and may directly inhibit
CXCL13 production. However, CPswith CD11cþ cells that lack
B cells are common, suggesting that additional signals regulate
CXCL13 production and Treg inhibition of these may also be
important. Tregs have also been suggested to play a role in
inducible bronchus-associated lymphoid tissue formation in the
lung as more develop in mice containing CCR7 / Tregs.37
Interestingly, CCR7 / mice also have a higher proportion of
larger solitary intestinal lymphoid tissue structures in the SI,8
suggesting Treg migration in response to CCL19 and/or CCL21
rather than CXCL13 may be critical in this process.
We have identified a novel ILF-regulating mechanism in the
colon involving microbiota-induced changes in IL-25 and IL-
23 expression. The role of the microbiota as a modulator of
health and disease, both mucosal and systemic, is growing in
importance. The CP/ILF system is a dynamic way in which the
immune system responds to the microbiota. The number,
maturation status, and cellular composition of ILFs are
influenced by many factors,16,46,47 and understanding how
perturbation of the CP/ILF system alters intestinal homeostasis
may be key to understanding how this breaks down. In the SI,
the relationship between microbial stimulation and ILF
formation is linear, providing an adaptable response for
microbiota control. In the colon, ILF regulation is more
complex, with the microbiota providing both stimulatory and
inhibitory signals for ILF formation, likely because of home-
ostasis that has to be reached with the higher microbial burdens
present. Disruption of this balance of positive and negative
factors regulating ILF development may be involved in the
development of colonic pathology, as many of the factors are
common to both processes, particularly as IL23R polymorph-
isms are associated with human inflammatory bowel disease.48
Lymphoid aggregates are a feature of human colonic inflam-
mation3 and have been associated with enhanced pathology in
mouse models.4–6,18 Furthermore, this mechanismmay also be
involved in nonmucosal chronic inflammatory diseases
associated with the development of tLTs where IL-23 and
Tregs are implicated in the pathogenesis.
METHODS
Mice. Mice were maintained under SPF conditions and all experiments
were carried out under the authority of a UK Home Office Project
Licence within the terms and conditions of the UK Home Office
‘‘Animals (scientific procedures) Act 1986.’’ All LTb / , CD11c-DTR,
IL-23p19 / , and IL-25 / 49 mice used in this study were bred and
maintained on a C57BL/6 background, with the exception of germ-free
CD1 mice. Germ-free mice were maintained under isolated conditions
and routinely checked for microbial contamination. Conventiona-
lization of germ-free mice was achieved by transfer to normal housing
and the addition of used bedding from conventionally housed mice. All
mice usedwere either littermates or were co-housed for aminimumof 2
weeks with used bedding exchanged between the cages.
In vivo treatments. For BM reconstitutions, mice were lethally
irradiated and reconstitutedwith appropriate BMvia tail vein injection
the following day. Reconstituted mice were not used until at least 10
weeks afterwards to permit ILF development. For CD11cþ cell
depletion, mice were intraperitoneally injected with 100 ng diphtheria
toxin (Sigma, Gillingham, UK) or an equivalent volume of phosphate-
buffered saline. For CD25þ cell depletion, mice were treated with
200 mg anti-CD25 mAb (PC61) or control rat IgG1 (eBRG1) (both
from Ebioscience, Hatfield, UK) weekly for 2 weeks.
Immunohistochemistry. Whole-mount immunostaining was per-
formed using a modification of a previously published method.50
Briefly,B4 cm pieces of intestine were washed in phosphate-buffered
saline before incubation in Hank’s balanced salt solution containing
5mM EDTA (both from Life Technologies, Paisley, UK) in shaking
incubator at 37 1C. The epithelium was washed off and the intestinal
pieces fixed in 10% formal saline (Cellpath, Powys, UK), washed in
Tris-buffered saline containing 0.1% Triton X-100 (Sigma), and
nonspecific binding blocked with 2.5% normal goat serum (Jackson
Immunoresearch, Newmarket, UK). Next, 6 mm cryosections were
fixed in acetone before blocking with 5% normal goat serum in Tris-
buffered saline containing 0.1% Triton X-100. Intestinal pieces and
cryosections were then stained with appropriate combinations of anti-
mouse rat anti-CD45-Alexa 488 mAb (RA3-6B2; Life Technologies),
hamster anti-CD11c-Alexa 647 mAb (N418; Biolegend, London, UK),
and/or rat anti-Foxp3-Alexa 647 mAb (FJK-16s; Ebioscience) or
purified rat anti-CD35mAb (8C12), rat anti-CD21/CD35mAb (7G6),
hamster anti-CD3mAb (145-2C11), rat anti-Thy1.2 (53-2.1) (all from
BD Biosciences, Oxford, UK), and/or polyclonal rabbit anti-IL-23p19
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(Abcam, Cambridge, UK) detected with goat anti-rat or anti-rabbit
IgGAlexa 594 conjugates (both fromLife Technologies). Sections were
mounted using fluorescentmountingmedium (Dako, Ely,UK).Where
appropriate, sections were counterstained with 4’,6-diamidino-2-
phenylindole (Life Technologies).
Microscopy. Whole-mount immunostained intestinal pieces were
visualized on a Nikon EC1 confocal microscope (Nikon, Kingston
upon Thames, UK). ILFs and mILFs were enumerated visually along
the whole length of the intestinal piece. Where appropriate, total
SI-ILFs were estimated from alternate SI pieces. At least three
representative images from each intestinal piece were captured and the
area of each ILF within these determined using ImageJ (http://
rsbweb.nih.gov/ij/), from which the mean ILF size per intestinal piece
was determined.
Images of cryosections were obtained using a Zeiss LSM5 Pascal
confocalmicroscope (Zeiss,WelwynGardenCity, UK). Analysis of CP
in cryosections was achieved by enumeration in 12–20 nonsequential
(100 mmapart) sections of 10 cmof terminal ileumand thewhole colon
from each mouse. For enumeration of IL-23p19þ and Foxp3þ cells,
cells were counted in images of all ILFs and adjacent areas of LP (2–14
per section) from three no-sequential sections.
Flow cytometry. Spleen and MLN cells were isolated by standard
mechanical disruption. Ileal and colonic LP cells were isolated by
enzymatic digestion as previously described.51 Surface staining was
achieved by incubation in anti-mouse CD16/CD32 mAb (2.4G2; BD
Biosciences) for 15min followed by incubation with anti-mouse CD4
FITC-conjugate mAb (H129.19), anti-mouse CD3 Pacific Blue-
conjugate mAb (500-A2) (both from BD Biosciences), anti-mouse
CD45 (B220) PE-Cy7-conjugate mAb (RA3-6B2; Life Technologies),
or anti-mouse IL-23R PE conjugate mAb (753317; R&D, Abingdon,
UK) for 30min where appropriate. Intracellular staining was per-
formed using a mouse Foxp3/Transcription factor staining buffer set
(Ebioscience) according to the manufacturer’s instructions using anti-
mouse Foxp3 Alexa 647-conjugate mAb (FJK-16s), anti-human/
mouse T-bet-PE-Cy7 conjugate mAb (ebio4b10), anti-mouse RORgt-
PE conjugate mAb (AFKJS-9) (all from Ebioscience) or anti-mouse
IgA-PE conjugatemAb (11-44-2; SouthernBiotech, Birmingham,AL).
Samples were acquired using a CyAn ADP flow cytometer (Dako) and
analyzed with Flowjo (Treestar, Ashland, OR). At least 50,000 events
per sample were collected.
Quantitative real-time reverse-transcriptase–PCR. Total RNA was
extracted from the colon using RNA-bee (AMS Biotechnology,
Abingdon, UK) and cDNA generated using First-Strand cDNA
synthesis kit (GE Healthcare, Little Chalfont, UK), both according to
the manufacturer’s instructions. Quantitative real-time reverse-
transcriptase–PCR was performed with Platinum SYBR Green qPCR
SuperMix-UDG (Life Technologies) according to the manufacturer’s
instructions using a Stratagene MX3005P (Agilent Technologies,
Waldbronn, Germany). Expression levels were determined relative to
Actb orGapdh. No template and no reverse transcription controls were
included for each primer. Primer sequences used were Actb (50-TGA
CAGGATGCAGAAGGAGA-30 and 50-GTACTTGCGCTCAG-
GAGGAGGAG-30); Gapdh (50-GGGTGTGAACCACGAGAAAT-30
and 50-CCTTCCACAATGCCAAAGTT-30); Il17a (50-TTTAACTC
CCTTGGCGCAAAA-30 and 50-CTTTCCCTCCGCATTGACAC-30);
Il23a (50-CAACTTCACACCTCCCTAC-30 and 50-CCACTGCT-
GACTAGAACTC-30); Il12b (50-GCAACGTTGGAAAGGAAAGA-30
and 50-AAAGCCAACCAAGCAGAAGA-30); Rorc (50-GACCCA-
CACCTCACAAATTGA-30 and 50-AGTAGGCCACATTACACTGC
T);Ccl20 (50-CGACTGTTGCCTCTCGTACA-30 and 50-AGCCCTTT
TCACCCAGTTCT-30); Cxcl13 (50-ACAGACTCCGAGCTAAAG
GTTG-30 and 50-AATGGGCTTCCAGAATACCG-30); Ccl19 (50-
GATCGCATCATCCGAAGACT-30 and 50-GAGGCCTGGTCCT
CTCTTCTTCT-30); Lta (50-CCCTCAGAAGCACTTGACC-30 and
50-CAGAGAAAACCACCTGGGAG-30); and Il25 (50-CAGCAAAG
AGCAAGAACC-30 and 50-CCTGTCCAACTCATAGC-30) (all
synthesized by Life Technologies).
Assessment of fecal IgA. Fecal IgA levels were determined by
enzyme-linked immunosorbent assay as previously described.50
Briefly, 10% homogenates of fecal samples (in phosphate-buffered
saline) were centrifuged at 12,000 g for 10min and the supernatants
collected. Supernatants were added to plates previously coated with
polyclonal goat anti-mouse IgA (Southern Biotech) and blocked with
5% bovine serum albumin/phosphate-buffered saline. Bound IgA was
detected using a goat anti-mouse IgA alkaline phosphatase-conjugate
(Southern Biotech) and visualized using p-nitrophenyl phosphate
liquid substrate (Sigma). The optical density was determined at 405 nm
using Wallac Victor 2 (PerkinElmer, Cambridge, UK) and converted
to ngml 1 using a standard curve of control mouse IgA (BD
Biosciences). Values were corrected for nonspecific binding using fecal
samples from severe combined immunodeficient mice.
Statistical analyses. Student’s t-test or one-way analysis of variance
with Tukey’s post-hoc test were performed using Prism 4 (Graphpad
Software, San Diego, CA). Results are expressed as mean±s.e.m. and
Po0.05 was considered significant.
SUPPLEMENTARYMATERIAL is linked to the online version of the paper
at http://www.nature.com/mi
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